Multiple Sclerosis (MS), a chronic autoimmune disease affecting the central nervous system, can have profound psychiatric implications. From mood disturbances to cognitive challenges, understanding the broader impact of MS is vital. The Journal of Clinical Psychiatry offers insights into the psychiatric aspects of MS, emphasizing evidence-based therapeutic approaches. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care to individuals with MS.
Multiple Sclerosis
Page 9
Recently published articles about Multiple Sclerosis
Clinical and Practical Psychopharmacology
Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes
January 7, 2026
About 0.04%-0.14% of women may use pregabalin during pregnancy. This article examines outcomes of pregnancies that were exposed to gabapentin.
Brief Report
Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial
January 7, 2026
Dysphoric mood was significantly reduced after an exercise intervention that included included high-impact treadmill interval training; there were no significant changes in other general symptoms.
